| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
7,603
|
12,728
|
5,102
|
21,863
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
7,603
|
12,728
|
5,102
|
21,863
| |
|
Operating Expenses |
|
Research Development | 22,332 | 21,540 | 20,233 | 20,010 |
|
Selling General and Administrative | 9,716 | 9,373 | 10,999 | 12,355 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(24,445)
|
(18,185)
|
(26,130)
|
(10,502)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 329 | 508 | 308 | 335 |
|
Earnings Before Interest And Taxes | (24,116) | (17,677) | (25,822) | (10,167) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (24,116) | (17,677) | (25,822) | (10,167) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (24,116) | (17,677) | (25,822) | (10,167) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(24,116)
|
(17,677)
|
(25,822)
|
(10,167)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(24,116)
|
(17,677)
|
(25,822)
|
(10,167)
|
|